one-year weight reduction with semaglutide or liraglutide in clinical practice vs Semaglutide: The Key Differences Comparing Semaglutide, Liraglutide, and Tirzepatide:
Description
Weigh the Risks and Benefits: Discuss concerns about efficacy variability and safety with a trusted healthcare provider before proceeding
Nature 515:182184
Food and Drug Administration approved Wegovy for reduction of risk for major adverse cardiovascular events in adults with overweight or obesity and established CVD
FDA-approved GLP-1 medications also carry a boxed warning based on thyroid tumors observed in animal studies
